Reproducibility of Post-Amphetamine [11C]FLB 457 Binding to Cortical D2/3 Receptors

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Narendran, Rajesh ^a   Himes, Michael ^a   Mason, N Scott ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; ISOREMOXIPRIDE C 11; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BINDING AFFINITY; BRAIN CORTEX; CEREBELLUM; COMPARTMENT MODEL; CONTROLLED STUDY; DISTRIBUTION VOLUME; DOPAMINE RELEASE; DOPAMINERGIC TRANSMISSION; FEMALE; HUMAN; HUMAN EXPERIMENT; ISOTOPE LABELING; LIGAND BINDING; MALE; MENTAL DISEASE; NORMAL HUMAN; POSITRON EMISSION TOMOGRAPHY; PROTEIN BLOOD LEVEL; RECEPTOR BINDING; RELIABILITY; REPRODUCIBILITY;

AMPHETAMINE; CARBON RADIOISOTOPES; CEREBRAL CORTEX; DOPAMINE; DOPAMINE ANTAGONISTS; HUMANS; KINETICS; MAGNETIC RESONANCE IMAGING; POSITRON-EMISSION TOMOGRAPHY; PYRROLIDINES; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; REPRODUCIBILITY OF RESULTS; SALICYLAMIDES;

EID: 84884799742     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0076905     Document Type: Article

References (42)

1. Laruelle M, Iyer RN, Al-Tikriti MS, Zea-Ponce Y, Malison R, et al. (1997) Microdialysis and SPECT measurements of amphetamine-induced dopamine release in nonhuman primates. Synapse 25: 1-14. doi:10.1002/(SICI)1098-2396(199701)25:1. PubMed: 8987142.
2. Laruelle M, Abi-Dargham A, van Dyck CH, Rosenblatt W, Zea-Ponce Y, et al. (1995) SPECT imaging of striatal dopamine release after amphetamine challenge. J Nucl Med 36: 1182-1190. PubMed: 7790942.
3. Kegeles LS, Zea-Ponce Y, Abi-Dargham A, Rodenhiser J, Wang T, et al. (1999) Stability of [123I]IBZM SPECT measurement of amphetamine-induced striatal dopamine release in humans. Synapse 31: 302-308. doi:10.1002/(SICI)1098-2396(19990315)31:4. PubMed: 10051112.
4. Breier A, Su TP, Saunders R, Carson RE, Kolachana BS, et al. (1997) Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: Evidence from a novel positron emission tomography method. Proc Natl Acad Sci U S A 94: 2569-2574. doi:10.1073/pnas.94.6.2569. PubMed: 9122236.
5. Carson RE, Breier A, deBartolomeis A, Saunders RC, Su TP, et al. (1997) Quantification of amphetamine-induced changes in [C-11]raclopride binding with continuous infusion. J Cereb Blood Flow Metab 17: 437-447. PubMed: 9143226.
6. Endres CJ, Kolachana BS, Saunders RC, Su T, Weinberger D, et al. (1997) Kinetic modeling of [C-11]raclopride: Combined PET-microdialysis studies. J Cereb Blood Flow Metab 17: 932-942. PubMed: 9307606.
7. Villemagne VL, Wong DF, Yokoi F, Stephane M, Rice KC, et al. (1999) GBR12909 attenuates amphetamine-induced striatal dopamine release as measured by [(11)C]raclopride continuous infusion PET scans. Synapse 33: 268-273. doi:10.1002/(SICI)1098-2396(19990915)33:4. PubMed: 10421707.
8. Laruelle M, Abi-Dargham A, van Dyck CH, Gil R, De Souza CD, et al. (1996) Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug free schizophrenic subjects. Proc Natl Acad Sci U S A 93: 9235-9240. doi:10.1073/pnas.93.17.9235. PubMed: 8799184.
9. Martinez D, Gil R, Slifstein M, Hwang DR, Huang Y, et al. (2005) Alcohol dependence is associated with blunted dopamine transmission in the ventral striatum. Biol Psychiatry 58: 779-786. doi:10.1016/j.biopsych.2005.04.044. PubMed: 16018986.
10. Volkow ND, Wang GJ, Fowler JS, Logan J, Gatley SJ, et al. (1997) Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects. Nature 386: 830-833. doi:10.1038/386830a0. PubMed: 9126741.
11. Martinez D, Narendran R, Foltin RW, Slifstein M, Hwang DR, et al. (2007) Amphetamine-induced dopamine release is markedly blunted in cocaine dependent subjects and predictive of the choice to self administer cocaine. Am J Psychiatry 164: 622-629. doi:10.1176/appi.ajp.164.4.622. PubMed: 17403976.
12. Martinez D, Saccone PA, Liu F, Slifstein M, Orlowska D, et al. (2012) Deficits in dopamine D(2) receptors and presynaptic dopamine in heroin dependence: commonalities and differences with other types of addiction. Biol Psychiatry 71: 192-198. doi:10.1016/j.biopsych.2011.08.024. PubMed: 22015315.
13. Narendran R, Frankle WG, Mason NS, Rabiner EA, Gunn RN, et al. (2009) Positron emission tomography imaging of amphetamine-induced dopamine release in the human cortex: a comparative evaluation of the high affinity dopamine D2/3 radiotracers [11C]FLB 457 and [11C]fallypride. Synapse 63: 447-461. doi:10.1002/syn.20628. PubMed: 19217025.
14. Narendran R, Mason NS, May MA, Chen CM, Kendro S, et al. (2011) Positron emission tomography imaging of dopamine D/ receptors in the human cortex with [(1) (1)C]FLB 457: reproducibility studies. Synapse 65: 35-40. doi:10.1002/syn.20813. PubMed: 20506186.
15. Narendran R, Mason NS, Chen CM, Himes M, Keating P, et al. (2011) Evaluation of dopamine D/ specific binding in the cerebellum for the positron emission tomography radiotracer [(1) (1)C]FLB 457: implications for measuring cortical dopamine release. Synapse 65: 991-997. doi:10.1002/syn.20926. PubMed: 21360596.
16. Narendran R, Jedema HP, Lopresti B, Mason NS, Gurnsey K, et al. (2013) Imaging dopamine transmission in the frontal cortex: a simultaneous microdialysis and [11C]FLB 457 PET study. Mol Psychiatry (In press).
17. Deuitch L, Gurnsey K, Ruskiewicz J, Himes M, Griswold K, et al. (2012). Imaging prefrontal cortical dopamine transmission with [11C]FLB 457 and amphetamine. New Orleans, LA.
18. Sudo Y, Suhara T, Inoue M, Ito H, Suzuki K, et al. (2001) Reproducibility of [11 C]FLB 457 binding in extrastriatal regions. Nucl Med Commun 22: 1215-1221. doi:10.1097/00006231-200111000-00008. PubMed: 11606887.
19. Vilkman H, Kajander J, Någren K, Oikonen V, Syvälahti E, et al. (2000) Measurement of extrastriatal D2-like receptor binding with [11C]FLB 457--a test-retest analysis. Eur J Nucl Med 27: 1666-1673. doi:10.1007/s002590000342. PubMed: 11105823.
20. Halldin C, Farde L, Högberg T, Mohell N, Hall H, et al. (1995) Carbon-11-FLB 457: a radioligand for extrastriatal D2 dopamine receptors. J Nucl Med 36: 1275-1281. PubMed: 7790956.
21. Narendran R, Frankle WG, Mason NS, Rabiner EA, Gunn RN, et al. (2009) Positron Emission Tomography Imaging of Amphetamine-Induced Dopamine Release in the Human Cortex: A comparative evaluation of the high affinity dopamine D2/3 radiotracers [11C]FLB 457 and [11C]fallypride. Synapse 63: 447-461. doi:10.1002/syn.20628. PubMed: 19217025.
22. Narendran R, Mason NS, Laymon CM, Lopresti BJ, Velasquez ND, et al. (2010) A comparative evaluation of the dopamine D(2/3) agonist radiotracer [11C](-)-N-propyl-norapomorphine and antagonist [11C]raclopride to measure amphetamine-induced dopamine release in the human striatum. J Pharmacol Exp Ther 333: 533-539. doi:10.1124/jpet.109.163501. PubMed: 20103586.
23. Bailer UF, Narendran R, Frankle WG, Himes ML, Duvvuri V, et al. (2012) Amphetamine induced dopamine release increases anxiety in individuals recovered from anorexia nervosa. Int J Eat Disord 45: 263-271. doi:10.1002/eat.20937. PubMed: 21541980.
24. Riccardi P, Li R, Ansari MS, Zald D, Park S, et al. (2005) Amphetamine-Induced Displacement of [(18)F] Fallypride in Striatum and Extrastriatal Regions in Humans. Neuropsychopharmacology 31: 1016-1026.
25. Cropley VL, Innis RB, Nathan PJ, Brown AK, Sangare JL, et al. (2008) Small effect of dopamine release and no effect of dopamine depletion on [(18)F]fallypride binding in healthy humans. Synapse 62: 399-408. doi:10.1002/syn.20506. PubMed: 18361438.
26. Olsson H, Halldin C, Swahn CG, Farde L, (1999) Quantification of [11C]FLB 457 binding to extrastriatal dopamine receptors in the human brain. J Cereb Blood Flow Metab 19: 1164-1173. PubMed: 10532641.
27. Hill AV, (1910) The possible effects of the aggregation of the molecules of haemoglobin on its disassociation curves. Phys Med Biol 1991: 749-761.
28. Gunn RN, Sargent PA, Bench CJ, Rabiner EA, Osman S, et al. (1998) Tracer kinetic modeling of the 5-HT1A receptor ligand [carbonyl-11C]WAY- 100635 for PET. Neuroimage 8: 426-440. doi:10.1006/nimg.1998.0379. PubMed: 9811559.
29. Abi-Dargham A, Laruelle M, Seibyl J, Rattner Z, Baldwin RM, et al. (1994) SPECT measurement of benzodiazepine receptors in human brain with [123-I]iomazenil: kinetic and equilibrium paradigms. J Nucl Med 35: 228-238. PubMed: 8294990.
30. Gandelman MS, Baldwin RM, Zoghbi SS, Zea-Ponce Y, Innis RB, (1994) Evaluation of ultrafiltration for the free fraction determination of single photon emission computerized tomography (SPECT) radiotracers: β-CIT, IBF and iomazenil. J Pharm Sci 83: 1014-1019. doi:10.1002/jps.2600830718. PubMed: 7965658.
31. Reimer ML, Mamer OA, Zavitsanos AP, Siddiqui AW, Dadgar D, (1993) Determination of amphetamine, methamphetamine and desmethyldeprenyl in human plasma by gas chromatography/negative ion chemical ionization mass spectrometry. Biol Mass Spectrom 22: 235-242. doi:10.1002/bms.1200220404. PubMed: 8481411.
32. Zhang Y, Brady M, Smith S, (2001) Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm. IEEE Trans Med Imaging 20: 45-57. doi:10.1109/42.906424. PubMed: 11293691.
33. Smith SM, Jenkinson M, Woolrich MW, Beckmann CF, Behrens TE, et al. (2004) Advances in functional and structural MR image analysis and implementation as FSL. NeuroImage 23 (Suppl 1):: S208-S219. doi:10.1016/j.neuroimage.2004.07.051. PubMed: 15501092.
34. Innis RB, Cunningham VJ, Delforge J, Fujita M, Gjedde A, et al. (2007) Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab 27: 1533-1539. doi:10.1038/sj.jcbfm.9600493. PubMed: 17519979.
35. Kirk RE, (1982) Experimental design: procedures for the behavioral sciences. Pacific Grove, California: Brooks/Cole Publishing Company.
36. Martinez D, Slifstein M, Broft A, Mawlawi O, Hwang DR, et al. (2003) Imaging human mesolimbic dopamine transmission with positron emission tomography. Part II: amphetamine-induced dopamine release in the functional subdivisions of the striatum. J Cereb Blood Flow Metab Off J International Society Of Cerebral Blood Flow Metabolism 23: 285-300.
37. Mawlawi O, Martinez D, Slifstein M, Broft A, Chatterjee R, et al. (2001) Imaging human mesolimbic dopamine transmission with positron emission tomography: I. Accuracy and precision of D(2) receptor parameter measurements in ventral striatum. J Cereb Blood Flow Metab Off J International Society Of Cerebral Blood Flow Metabolism 21: 1034-1057.
38. Mawlawi O, Martinez D, Slifstein M, Broft A, Chatterjee R, et al. (2001) Imaging human mesolimbic dopamine transmission with positron emission tomography: I. Accuracy and precision of D2 receptor parameter measurements in ventral striatum. J Cereb Blood Flow Metab 21: 1034-1057. PubMed: 11524609.
39. Narendran R, Frankle WG, Mason NS, Laymon CM, Lopresti BJ, et al. (2009) PET Imaging of D2/3 agonist binding in healthy human subjects with the radiotracer [11C]-N-propyl-nor-apomorphine (NPA): preliminary evaluation and reproducibility studies. Synapse 63: 574-584. doi:10.1002/syn.20633. PubMed: 19301416.
40. Narendran R, Mason NS, May MA, Chen CM, Kendro S, et al. (2011) Positron emission tomography imaging of dopamine D(2)/(3) receptors in the human cortex with [(1) (1)C]FLB 457: reproducibility studies. Synapse 65: 35-40. doi:10.1002/syn.20813. PubMed: 20506186.
41. Laruelle M, (2000) Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review. J Cereb Blood Flow Metab Off J International Society Of Cerebral Blood Flow Metabolism 20: 423-451. PubMed: 10724107.
42. Narendran R, Mason NS, Laymon C, Lopresti B, Velasquez N, et al. (2010) A comparative evaluation of the dopamine D2/3 agonist radiotracer [11C]NPA and antagonist [11C]raclopride to measure amphetamine-induced dopamine release in the human striatum. J Pharmacol Exp Ther 63: 574-584.